Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.
about
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.Adjuvant therapy for high-risk localized kidney cancer- emerging evidence and future clinical trials.Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.
P2860
Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contemporary trends in high-do ...... arcinoma in the United States.
@en
Contemporary trends in high-do ...... arcinoma in the United States.
@nl
type
label
Contemporary trends in high-do ...... arcinoma in the United States.
@en
Contemporary trends in high-do ...... arcinoma in the United States.
@nl
prefLabel
Contemporary trends in high-do ...... arcinoma in the United States.
@en
Contemporary trends in high-do ...... arcinoma in the United States.
@nl
P2093
P2860
P1433
P1476
Contemporary trends in high-do ...... carcinoma in the United States
@en
P2093
Benjamin I Chung
Christopher B Allard
Eric A Singer
Francisco Gelpi-Hammerschmidt
Ilker Tinay
Izak Faiena
Lauren C Harshman
Steven L Chang
Toni K Choueiri
P2860
P304
P356
10.1016/J.UROLONC.2015.06.014
P50
P577
2015-07-22T00:00:00Z